Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Lisa M, Fleming"'
Autor:
Alireza, Ghajar, Cesar Palacios, Ordonez, Binu, Philips, Pablo Quintero, Pinzon, Lisa M, Fleming, Shweta R, Motiwala, Roy, Sriwattanakomen, Jennifer E, Ho, E Wilson, Grandin, Marwa, Sabe, Arthur Reshad, Garan
Publikováno v:
International Journal of Cardiology. 367:45-48
Observational and trial data have revealed significant improvement in cardiogenic shock (CS) mortality due to acute myocardial infarction (AMI) after introducing early coronary revascularization. Less is known about CS mortality due to heart failure
Autor:
Marwa A. Sabe, Kevin F. Kennedy, Arthur R. Garan, Isabel Balachandran, Wilson Grandin, Shweta R. Motiwala, Lisa M. Fleming, Jose Nunez, Pablo A. Quintero
Publikováno v:
Circulation. 142
Introduction: Hemocompatibility-related adverse events (HRAE) including stroke, pump thrombosis, and gastrointestinal bleeding (GIB), is a major cause of mortality in patients with continuous flow left ventricular assist devices (CF-LVAD). Digoxin (d
Autor:
Shweta R. Motiwala, Arthur R. Garan, Lisa M. Fleming, Jose Nunez, Marwa A. Sabe, Nirupama Vellanki, Kevin F. Kennedy, Loryn Feinberg, E.W. Grandin, Pablo A. Quintero
Publikováno v:
Circulation. 142
Intro: Women have been shown to have higher risk of bleeding after adverse cardiovascular events. Bleeding events are a major cause of morbidity and mortality in patients with continuous flow left ventricular assist devices (cf-LVADs). There are few
Autor:
Marwa A. Sabe, Kevin Kennedy, Pablo A. Quintero, Loryn Feinberg, Lisa M. Fleming, E. Wilson Grandin, Jordan B. Strom, Shweta R. Motiwala, Nirupama S. Vellanki, A. Reshad Garan
Publikováno v:
Journal of Cardiac Failure. 26:S145
Introduction Despite an increase in the prevalence of advanced heart failure in women, women are less likely to be treated with durable LVAD therapy and may have increased risk of early post LVAD complications. Previous studies have shown that women
Autor:
Michael C. Gavin, Kevin Kennedy, Ginger Y. Jiang, Pablo Quintero Pinzon, Marwa A. Sabe, Arthur Garan, Lisa M. Fleming, Jordan B. Strom
Publikováno v:
Journal of the American College of Cardiology. 75:914
Autor:
Robb D. Kociol, Xin Zhao, Adam D. DeVore, Adrian F. Hernandez, Clyde W. Yancy, Paul A. Heidenreich, Lisa M. Fleming, Gregg Fonarow
Publikováno v:
Circulation: Heart Failure. 11
Background: Early ambulation (EA) is associated with improved outcomes for mechanically ventilated and stroke patients. Whether the same association exists for patients hospitalized with acute heart failure is unknown. We sought to determine whether
Autor:
Robb D. Kociol, Lisa M. Fleming
Publikováno v:
Current Heart Failure Reports. 11:178-187
Heart failure readmissions result in significant costs to the health care system and to patients' quality of life, but programs to reduce readmissions have met with mixed success. Successful strategies have included multidisciplinary hospital-based q
Publikováno v:
Catheterization and Cardiovascular Interventions. 80:E23-E29
Background: Bleeding events are common after percutaneous coronary intervention (PCI) and have been shown to increase mortality in studies of acute coronary syndrome (ACS) and anti-thrombotic therapy. Despite this evidence, bleeding has not been incl
Autor:
David R. Shalinsky, Roland G. Henry, Nola M. Hylton, Dana D. Hu-Lowe, Jessica Gibbs, Ka Loh Li, John W. Park, Lisa J. Wilmes, Lisa M. Fleming, Donghui Wang, Teresa M. McShane, Maria G. Pallavicini, Ying Lu, Robert C. Brasch, Savannah C. Partridge
Publikováno v:
Magnetic Resonance Imaging. 25:319-327
Dynamic contrast-enhanced MRI (DCE-MRI) was used to noninvasively evaluate the effects of AG-03736, a novel inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases, on tumor microvasculature in a breast cancer model. First, a
Autor:
Adin-Christian Andrei, Philip Jones, Paul S. Chan, Lisa M. Fleming, Steven A. Farmer, Thomas M. Maddox
Publikováno v:
Circulation. Cardiovascular quality and outcomes. 9(1)
Background— There is a reported association between high clinical volume and improved outcomes. Whether this relationship is true for outpatients with coronary artery disease (CAD), heart failure (HF), and atrial fibrillation (AF) remains unknown.